Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by pro-gressive impairment of memory and other cognitive functions. Regression analy-sis has been studied to relate neuroimaging measures to cognitive status. However, whether these measures have further predictive power to infer a trajectory of cog-nitive performance over time is still an under-explored but important topic in AD research. We propose a novel high-order multi-task learning model to address this issue. The proposed model explores the temporal correlations existing in imag-ing and cognitive data by structured sparsity-inducing norms. The sparsity of the model enables the selection of a small number of imaging measures while main-taining high prediction accu...
Alzheimer's disease (AD) is characterised by a dynamic process of neurocognitive changes from normal...
Objective: Machine learning approaches for predicting Alzheimer’s disease (AD) progression can subst...
IntroductionModels characterizing intermediate disease stages of Alzheimer’s disease (AD) are needed...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Alzheimer's Disease (AD) is a chronic neurodegenerative disease that severely impacts patients' thin...
poster abstractRegression models have been widely studied to investigate whether multimodal neuroima...
Machine learning (ML) techniques for predicting the progression of Alzheimer's disease (AD) can grea...
Prediction of Alzheimers disease (AD) progression based on baseline measures allows us to understand...
Computational models predicting symptomatic progression at the individual level can be highly benefi...
Computational models predicting symptomatic progression at the individual level can be highly benefi...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Alzheimer’s disease (AD) is known as one of the major causes of dementia and is characterized by slo...
Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by a decline in cogniti...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
Recently, there have been a wide spectrum of ma-chine learning models developed to model Alzheimer’s...
Alzheimer's disease (AD) is characterised by a dynamic process of neurocognitive changes from normal...
Objective: Machine learning approaches for predicting Alzheimer’s disease (AD) progression can subst...
IntroductionModels characterizing intermediate disease stages of Alzheimer’s disease (AD) are needed...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Alzheimer's Disease (AD) is a chronic neurodegenerative disease that severely impacts patients' thin...
poster abstractRegression models have been widely studied to investigate whether multimodal neuroima...
Machine learning (ML) techniques for predicting the progression of Alzheimer's disease (AD) can grea...
Prediction of Alzheimers disease (AD) progression based on baseline measures allows us to understand...
Computational models predicting symptomatic progression at the individual level can be highly benefi...
Computational models predicting symptomatic progression at the individual level can be highly benefi...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Alzheimer’s disease (AD) is known as one of the major causes of dementia and is characterized by slo...
Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by a decline in cogniti...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer’s d...
Recently, there have been a wide spectrum of ma-chine learning models developed to model Alzheimer’s...
Alzheimer's disease (AD) is characterised by a dynamic process of neurocognitive changes from normal...
Objective: Machine learning approaches for predicting Alzheimer’s disease (AD) progression can subst...
IntroductionModels characterizing intermediate disease stages of Alzheimer’s disease (AD) are needed...